Abstract
Reactive oxygen species play a key role in intestinal inflammation, although interventional studies using antioxidants have shown only weak beneficial effects both in humans and animals. Hence, our aim was to examine the possible beneficial effect of the antioxidant 2-mercaptoethane sulfonate (Mesna) on experimental colitis. Colitis was induced in rats by intrarectal instillation of trinitrobenzene sulfonic acid (TNB) followed immediately by intrarectal Mesna or saline, administered for 14 days, twice daily. A beneficial effect of Mesna was observed, resulting in a significant reduction in inflammation followed by almost full recovery. iNOS mRNA expression and myeloperoxidase (MPO) activity were significantly increased in the TNB-Mesna group. These results suggest that the induction of iNOS in the presence of Mesna reduced intestinal inflammation. Mesna probably resolved this inflammation by scavenging reactive oxygen species generated by the augmented infiltration of polymorphonuclear leukocytes.
Similar content being viewed by others
References
Keshavarzian A, Morgan G, Sedghi S, Gordon JH, Doria M: Role of reactive oxygen metabolites in experimental colitis. Gut 31:786-790, 1990
Verspaget HW, Mulder TP, Van-Der-Sluys-Veer A, Pena AS, Lamers CB: Reactive oxygen metabolites and colitis: a disturbed balance between damage and protection. A selective review. Scand J Gastroenterol (suppl) 188:44-51, 1991
Allgayer H: Clinical relevance of oxygen radicals in inflammatory bowel disease-facts and fashion. Klin Wochenschr 69:1001-1003, 1991
Kitahora T, Suzuki K, Asakura H, Yoshida T, Suematsu M, Watanabe M, Aiso S, Tsuchiya M: Active oxygen species generated by monocytes and polymorphonuclear cells in Crohn's disease. Dig Dis Sci 33:951-955, 1988
Shiratora A, Aoki S, Takada H, Kiriyama H, Ohto K, Hai K, Teraoko H, Matano S, Matsumoto K, Kamii K: Oxygen-derived free radicals generating capacity of polymorphonuclear cells in patient with ulcerative colitis. Digestion 44:163-171, 1989
Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK: Enhanced colonic nitric oxide generation and stimulated nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 36:718-723, 1995
Boughton Smith NK, Evans SM, Hawkey CJ, Cole AT, Balsitis M, Whittle BJ, Moncada S: Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 342:338-340, 1993
Ferreti M, Gionchette P, Rizzello F, Venturi A, Stella P, Corti F, Mizrahi J, Miglioli M, Campieri M: Intracolonic release of nitric oxide during trinitrobenzenesulfonic acid rat colitis. Dig Dis Sci 42:2606-2611, 1997
Roediger WE, Lawson Mj, Nance SH, Radcliffe BC: Detectable colonic nitrate levels in inflammatory bowel disease-mucosal or bacterial malfunction. Digestion 35:199-204, 1986
Parks DA, Bulkey GB, Granger DN: Role of oxygen-derived free radicals in digestive tract disease. Surgery 94:415-422, 1983
Miller MJ, Sadowska-krowicka H, Chotinaruemol S, Kakkis JL, Clark OA: Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 264:11-16, 1992
Rachmilewitz D, Karmeli F, Okon E, Bursztyn M: Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 36:247-255, 1995
Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG: The selective beneficial effect of nitric oxide inhibition in experimental colitis. Am J Physiol 268:G673-G684, 1995
Yoshida Y, Iwai A, Itoh K, Tanaka M, Kato S, Hokari R, Miyahara T, Koyama H, Miura S, Kobayashi M: Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther 14(suppl 1):26-32, 2000
Pfeiffer CJ, Qiu BS: Effect of chronic nitric oxide synthase inhibition on TNB-induced colitis in rats. J Pharm Pharmocol 47:827-832, 1995
Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel DJ, Loscalzo J, Xavier RJ, Podolsky DK: Peroxynitrite-induced rat colitis—a new model of colonic inflammation. Gastroenterology 105:1681-1688, 1993
Tang LD, Sun JZ, Wu K, Sun CP, Tang ZM: Beneficial effects of N-acetylcysteine and cysteine in stunned myocardium in perfused rat heart. Br J Pharmacol 102:601-606, 1991
Grisham MB, McCord JM: Chemistry and cytotoxicity of reactive oxygen metabolites. In AE Taylor, S Matalon, P Ward (eds). Physiology of Oxygen Radicals. Bethesda, American Physiological Society, pp 1-18, 1986
Gressier B, Lebegue N, Brunet C, Luyckx M, Dine T, Cazin M, Cazin JC: Scavenging of reactive oxygen species by letosteine, a molecule with two blocked-SH groups. Comparison with free-SH drugs. Pharm World Sci 17:76-80, 1995
Gressier B, Cabanis A, Lebegue S, Brunet C, Dine T, Luyckx M, Cazin M, Cazin JC: Decrease of hypochlorous acid and hydroxyl radical generated by stimulated human neutrophils: Comparison in vitro of some thiol-containing drugs. Methods Find Exp Clin Pharmacol 16:9-13, 1994
Goren MP, McKenna LM, Goodman TL: Combined intravenous and oral Mesna in outpatient treated with ifosfamide. Cancer Chemother Pharmacol 40:371-375, 1997
Mashiach E, Sela S, Weinstein T, Cohen HI, Shasha SM, Kristal B: Mesna: a new renoprotective antioxidant in ischemic acute renal failure. Nephrol Dial Transplant 16:542-551, 2001
Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL: Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96:795-803, 1989
Vacca LL: Laboratory Manual of Histochemistry, Raven Press, New York, 1985
Bradley PP, Priebat DA, Christenen RD, Rothstein G: Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206-209, 1982
Beers F, Sizer IW: A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 195:133-140, 1952
Krug MS, Berger SL: First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol 152:316-325, 1987
Rubinstein I, Abassi Z, Coleman R, Milman F, Winaver J, Better OS: Involvement of nitric oxide in experimental muscle crush injury. Clin Invest 101:1325-1233, 1998
Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87:1344-1350, 1984
Mullane KM, Kraemar R, Smith B: Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium. J Pharmacol Methods 14:157-167, 1985
McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P: Role on inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 45:864-873, 1999
McCafferty D, Mudgett JS, Swain MG Kubes P: Inducible nitric oxide syntase plays a critical role in resolving intestinal inflammation. Gastroenterology 112:1022-1027, 1997
Kubes P, Kurose I, Granger DN: NO donors prevent integrin-induced leukocyte adhesion, but not P-selectin dependent rolling in post ischemic venules. Am J Physiol 267:H931-H937, 1994
Kubes P, Suzuki M, Granger DN: Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 88:4651-4655, 1991
Gaboury JP, Niu XF, Kubes P: Nitric oxide inhibits numerous features of mast cell-induced inflammation. Circulation 93:318-326, 1996
Belenky SN, Robbins RA, Rennard SI, Gossman GL, Nelson KJ, Rubinstein I: Inhibitors of nitric oxide synthase attenuate human neutrophil chemotaxis in vitro. J Lab Clin Med 122:388-394, 1993
Yamada T, Zimmerman BJ, Specian RD, Grisham MB: Role of neutrophils in acetic acid-induced colitis in rats. Inflammation 15:399-411, 1991
Sekizuka E, Grisham MB, Li M, Deitch EA, Granger DN: Inflammation-induced intestinal hyperemia in the rat: Role of neutrophils. Gastroenterology 95:1528-1534, 1988
Buell MG, Berin MC: Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat. Dig Dis Sci 39:2575-2588, 1994
Umemura T, Hasegawa R, Sai-Kato K, Nishikawa A, Furukawa F, Toyokuni S, Uchida K, Inoue T, Kurokawa Y: Prevention by 2-mercaptoethane sulfonate and N-acetylcysteine of renal oxidative damage in rats treated with ferric nitrilotriacetate. Jpn J Cancer Res 87:882-886, 1996
Rachmilewitz D, Okon E, Karmeli F: Sulphydryl blocker induced small intestinal inflammation in rats: a new model mimicking Chron's disease. Gut 41:358-365, 1997
Harris ED: Regulation of antioxidant enzymes. FASEB J 6:2675-2683, 1992
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Shusterman, T., Sela, S., Cohen, H. et al. Effect of the Antioxidant Mesna (2-Mercaptoethane Sulfonate) on Experimental Colitis. Dig Dis Sci 48, 1177–1185 (2003). https://doi.org/10.1023/A:1023741518385
Issue Date:
DOI: https://doi.org/10.1023/A:1023741518385